
iSiP, Inc. is focused on revolutionizing the drug discovery process by integrating AI and physical simulation to enhance efficiency and scientific accuracy. Their innovative approach aims to create a robust pipeline for new drug development, contributing to the pharmaceutical industry as a major export sector by 2035. The company emphasizes a three-way business model that benefits purchasers by providing better treatments, sellers by establishing a domestic research base, and society by generating sustainable jobs and advancing scientific research.

iSiP, Inc. is focused on revolutionizing the drug discovery process by integrating AI and physical simulation to enhance efficiency and scientific accuracy. Their innovative approach aims to create a robust pipeline for new drug development, contributing to the pharmaceutical industry as a major export sector by 2035. The company emphasizes a three-way business model that benefits purchasers by providing better treatments, sellers by establishing a domestic research base, and society by generating sustainable jobs and advancing scientific research.